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Abstract
Objectives To evaluate the completeness of descriptions of
non-pharmacological interventions in randomised trials, identify which
elements are most frequently missing, and assess whether authors can
provide missing details.
Design Analysis of consecutive sample of randomised trials of
non-pharmacological interventions.
Data sources and study selection All reports of randomised trials of
non-pharmacological interventions published in 2009 in six leading
general medical journals; 133 trial reports, with 137 interventions, met
the inclusion criteria.
Data collection Using an eight item checklist, two raters assessed the
primary full trial report, plus any reference materials, appendices, or
websites. Questions about missing details were emailed to corresponding
authors, and relevant items were then reassessed.
ResultsOf 137 interventions, only 53 (39%) were adequately described;
this was increased to 81 (59%) by using 63 responses from 88 contacted
authors. Themost frequently missing itemwas the “interventionmaterials”
(47% complete), but it also improved the most after author response
(92% complete). Whereas some authors (27/70) provided materials or
further information, other authors (21/70) could not; their reasons included
copyright or intellectual property concerns, not having the materials or
intervention details, or being unaware of their importance. Although 46
(34%) trial interventions had further information or materials readily
available on a website, many were not mentioned in the report, were
not freely accessible, or the URL was no longer functioning.
Conclusions Missing essential information about interventions is a
frequent, yet remediable, contributor to the worldwide waste in research
funding. If trial reports do not have a sufficient description of interventions,
other researchers cannot build on the findings, and clinicians and patients
cannot reliably implement useful interventions. Improvement will require
action by funders, researchers, and publishers, aided by long term
repositories of materials linked to publications.
Introduction
Secret remedies—branded drugs whose ingredients were kept
secret—were once common, until successful campaigns in the
United States and United Kingdom in the early 20th century
required labels to include all ingredients.1 This policy allowed
independent evaluation of treatments and provided clinicians
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and consumers with the means to understand what they were
considering using.
However, a treatment consists of more than the list of
ingredients: the dose, frequency, monitoring, titration, mode of
delivery, and duration of use can all influence efficacy and
safety. Such details are often not well described in trials. For
example, a recent analysis found that only 11% of 262 trials of
cancer chemotherapy provided complete details of the trial
treatments.2 The most common missing elements were dose
adjustment and pre-medications, but 16% omitted even the route
of administration of the drug. The completeness of descriptions
of treatments may be worse for non-pharmacological
interventions: one analysis found that 67% of drug treatment
descriptionswere adequate comparedwith only 29%of non-drug
treatments. However, this analysis also included systematic
reviews, which were less informative on average than were
reports of individual trials.3
Unlike the bogus “secret remedies” of the 19th century, the
current incomplete descriptions of interventions are likely to
arise from poor communication and lack of awareness of the
matter among authors and lack of attention by reviewers and
editors. However, the consequences are similar: other researchers
cannot replicate and build on research findings, and clinicians
and patients cannot reliably adopt interventions shown to be
useful.
To better understand what elements are most frequently missing
from descriptions, and whether this is remediable, we aimed to
assess the completeness of descriptions of non-pharmacological
interventions in reports of trials published in major general
medical journals, using a checklist to evaluate the completeness,
and to assess whether missing details can be obtained by
contacting authors of trial reports.
Methods
Search strategy and selection of reports of
trials
We included all reports of randomised controlled trials of
non-pharmacological interventions published in 2009 in one of
the six leading general medical journals (based on ISI Web of
Knowledge impact factor for 2010): New England Journal of
Medicine, JAMA, Lancet, Annals of Internal Medicine, PLOS
Medicine, and BMJ. We defined non-pharmacological
interventions as interventions including surgery, technical
procedures, devices, rehabilitation, psychotherapy, behavioural
interventions, and complementary and alternative medicine.4
We excluded reports if they evaluated a pharmacological
intervention, a screening programme, or a diagnostic technique
(for example, endoscopy) or if they reported secondary analyses,
such as an economic analysis of a non-pharmacological
intervention trial for which the main results had been published
elsewhere or before 2009. Reports were eligible if a
non-pharmacological intervention had been compared with a
pharmacological intervention or when a complex intervention
included a pharmacological component if the major focus was
a non-pharmacological component. When reports contained
evaluations of more than one non-pharmacological intervention
(such as by using three groups or a factorial design), we rated
the descriptions of each intervention separately.
An experienced medical librarian searched PubMed in April
2011, using the restrictions of year (2009), publication type
(“randomized controlled trial”), and journal title (the six chosen
journals). Two authors (TH and PG) screened the 358 titles and
abstracts retrieved, identified reports that might meet the
inclusion criteria, and retrieved the complete and unabridged
reports (n=138). Disagreements about unclear eligibility were
resolved by discussion.
Rating of intervention descriptions
Before rating the reports in our study sample, we rated a sample
of reports that met our eligibility criteria but had been published
in 2008, discussed responses, and continued rating reports until
high agreement was reached. Two authors (TH and PG)
independently used a checklist to rate the description of the
interventions in each eligible report. The checklist is based on
the work of Davidson and colleagues and the CONSORT
extension statement for non-pharmacological interventions and
has been used, in a slightly modified form, in a previous study.4-6
The checklist contains eight items (table 1⇓). Seven of the items
are rated as “Yes” (indicating that the element of the intervention
had been clearly described) or “No” (not reported or not clearly
described). Each item in the checklist had an explanatory
statement that guided the raters in the scope and interpretation
of the item. For “No” responses, we recorded detailed comments
about what was missing. The eighth item was an overall
question: “Is the description of the intervention complete?”
Reports could score a “Yes” on this item only if all other items
had been rated as “Yes.” We also routinely and systematically
assessed whether the intervention details might have been
described further in other sources (such as websites, online
appendices, or reference materials). If so, we used these
additional sources when completing the checklist items.
Disagreements in ratings were resolved by discussion, with
reference to the explanatory statement for the relevant item/s,
between the two raters.
For all reports with any checklist items rated as having an
incomplete description, the raters generated a list of questions
about element/s of the intervention that were missing or unclear.
We emailed these questions to the corresponding author. If no
response was received within four weeks, we sent up to two
reminder emails at four weekly intervals. When responses were
received from authors, the raters collaboratively re-rated the
relevant items as either “Yes—clear after author reply” or
“No—not clear after author reply.”
Data analysis
We entered initial and follow-up ratings of reports and questions
emailed to authors into a customised database. We used Excel
to analyse data descriptively.
Results
Of the 138 reports for which we were able to obtain full texts,
we excluded five (three economic evaluations and two long
term follow-up results) and four reports contained evaluations
of two non-pharmacological interventions (see supplementary
figure). Our final sample thus contained published reports of
137 interventions from 133 trials. Table 2⇓ shows the journals
in which the reports had been published and the categories of
intervention that had been evaluated.7
Completeness of intervention descriptions
Figure 1⇓ shows, for each of the checklist items, the percentage
of interventions that were clearly described in primary reports
and after reply from authors of trial. Overall, 53 (39%) of the
interventions were adequately described in primary reports, and
this increased to 81 (59%) after contact with authors. The
checklist item about intervention materials scored most poorly
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in primary reports (complete in 64 (47%) of interventions) but
was also the item that showed the most improvement (complete
in 126 (92%)) after reply from trial authors.
We sent questions to authors of reports about 88 of the
interventions (from 84 trials), with a mean of 2.7 (SD 1.5, range
1-6) questions per author. We received no response from 25
authors after two reminders. On the basis of the responses from
the 63 authors who replied, the overall rating changed from
“No” to “Yes” for 29 of the interventions and remained as
“No—description not complete” for 34 interventions (for
example, requested materials were not sent or the response did
not clearly answer the question). Table 3⇓ provides verbatim
examples of incomplete reporting of descriptions of
interventions from the primary reports.
Process of obtaining complete description of
intervention—an example
Figure 2⇓ illustrates the key steps in the study methods and the
process of obtaining a complete description of an intervention
for one of the included reports. After the initial rating of this
report,8 four items—setting, provider, procedure, and
materials—were assessed as incompletely described, so the
overall rating item (“Is the overall description complete?”) was
“No.”We emailed the corresponding author with five questions
(shown in fig 2⇓). On the basis of the responses, each of these
items and the overall rating were changed to “Yes.” By
contacting the author, we also learnt that even though the trial
used a DVD that was not available, an iPhone app (in Dutch
only) containing the exercises and exercise schedule was now
available, as was a YouTube clip of the exercises. However,
neither of these resources was mentioned in the 2009 report.
Materials used in interventions
Most of the questions that were sent to authors were about
materials used in the intervention. We emailed 70 authors with
at least one question about materials and received responses
from 27 authors that enabled the rating of the materials item to
be changed to “Yes.” Typically this was because authors sent
copies of the materials used (for example, written materials used
with study participants, such as patient education materials or
staff training materials) or provided information about how to
access interventionmaterials or further details (such as a website
or journal article that was not referenced in the primary report).
Of the other 21 authors who responded, the rating for the
materials item, and the overall rating, remained as “No.” The
box shows typical reasons for this.
Further intervention information contained
on websites
For one third (n=46) of the interventions, a relevant website
existed that contained further information about the intervention
or at least some of the materials used in the intervention. Only
35 (76%) of these websites were mentioned in the report and,
of these, just over half (19; 54%) were freely accessible. Many
websites were behind a paywall, and for others the website
address provided in the report no longer existed. Several
interventions had relevant websites, but we learnt of these only
by contacting the author or through internet search engines.
Figure 3⇓ summarises these websites according to howwe found
out about the website’s existence (for example, mentioned in
the original report, email from author), whether any website
links provided worked, and whether the site content was
accessible free of charge.
Discussion
More than half (61%) of the interventions assessed in this study
were not described in sufficient detail in the published primary
report to enable replication of the intervention in practice. This
problem is partly remediable: a third of the incompletely
described interventions could be completed by contacting study
authors for further information. Obtaining this additional
information took some effort: compilation of omissions, up to
three emails, and subsequent piecing together of information
from disparate sources. Clinicians wishing to use an intervention
in practice are unlikely to invest this amount of time in obtaining
the necessary details and materials. Even for trials in which the
intervention was not effective, complete descriptions of
interventions are important for other groups of research users.
For example, this includes other researchers (who may wish to
build on the trial or modify the intervention in some way) and
systematic reviewers (who need details of intervention to assist
with assessing and understanding heterogeneity).
Most interventions included some materials, such as written
materials for educating patients or materials for training staff,
without which the interventions cannot be used in practice.
Despite their importance, just over half (53%) of the reports
neither sufficiently described these materials nor gave details
about how to obtain copies. Consequently, questions about
materials were ourmost common question to authors. Comments
from some authors suggested a lack of awareness of the
importance of making intervention materials available. Other
authors were reluctant to make materials available publicly
(often owing to real or perceived concerns about copyright or
intellectual property). Sometimes, corresponding authors no
longer had copies of the materials or were uncertain about
intervention details.
Several previous studies have documented deficiencies in the
descriptions of interventions: an analysis of patient education
interventions found that only 17% were replicable, with
information about the content of sessions most commonly
missing9; none of 11 trials of music therapy provided all
necessary details10; and an analysis of 158 surgical studies found
that only 41% provided some details of the surgical procedure.11
However, only one previous study seems to have included
writing to authors to obtain additional information; a checklist
was not used, and only a small sample of non-pharmacological
interventions was included.3
Recommendations
The omission of essential information about interventions is a
substantial, yet remediable, contributor to the enormous
worldwide waste in research funding that occurs because
research is unpublished or unusable.12 Reducing this waste will
require action by funders, researchers, and publishers at multiple
stages, including pre-submission, editorial review, and
publication. However, missing details in the reports of
intervention studies is part of a wider problem of non-replicable
interventions in trials and systematic reviews. This has been the
topic of a consensus meeting,13 which made several
recommendations. Two of these are relevant to the problems
identified in this research.
A key recommendation was that: “The reporting standards for
interventions in trials (CONSORT, etc) and systematic reviews
(PRISMA) should be improved and standardised (specific
checklists).” The CONSORT extension statement for the
reporting of randomised trials of non-pharmacologic treatment
contains four intervention related items: precise details of the
intervention, description of the intervention components (and
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Reasons given for study intervention materials being unavailable
Category of reason (number of authors providing a response in this category) and illustrative quotes from authors:
Materials not publicly available (9)
“Due to legal copyright restrictions at my university I am unable to send”
“Not publicly available because we based them on materials provided by our local government”
“Not publicly available—only to our trainers”
“Not yet—they will be made publicly available within two years”
“No it is not. Attached is a table of contents”
“The training materials from the trial are not online—we had no real reason to do that”
Corresponding author did not have copy of materials to send or could not provide further details about intervention (8)
“People originally in the position have moved on”
“I am unable to find . . . my old computer files”
“I’m afraid I no longer have access to those materials”
“I do not have it”
“I am not able to answer most of your questions. I was not involved with running the trial, only analysing and reporting on the QOL results
after the data was collected”
“I can’t provide these”
Other (3)
“You will have to read the literature”
“No, is in Dutch”
“The [materials] are tailored, thus it is difficult to disseminate. We could send an example”
Materials were previously publicly available but no longer are (2)
“URL doesn’t exist anymore”
“We had been making it previously available, but need to update it, so are no longer”
where applicable, description of tailoring procedures), details
of how interventions were standardised, and details of how
adherence to the protocol by care providers was assessed.4
However, this CONSORT extension does not mention
intervention materials, which we found to be the most poorly
reported, and remediable, element. The mere existence of an
appropriately detailed checklist is unlikely to be sufficient to
improve quality of reporting. Few journals request the use of
extension statements, and, even when endorsed by journals,
subsequent adherence to them by published reports does not
necessarily occur.14 Journal editors and reviewers have a
responsibility to be aware of the importance of complete
reporting of non-pharmacological interventions and to
implement policies and processes to ensure that this occurs.
A second recommendation was that: “A stable ‘intervention
bank’ should be established (e.g. videos, manuals, and fidelity
tools linked to trial registration number) to overcome the
problem of word restrictions in journals, etc.” Although hosting
intervention materials on websites may seem to be a logical
way of making them available, problems such as maintaining
operational sites were already apparent in this sample of quite
recent reports. One striking finding was that a third of the trials
had a website with additional intervention information/materials,
but a quarter of these were not mentioned and many were not
freely accessible or the URL no longer worked. This suggests
that responsibility for maintaining websites that contain
intervention details should not lie solely with journals, authors,
or their institutions, but instead with organisations that have
greater stability and longevity. Similar to drug treatments in
pharmacopoeias, an equivalent compilation for non-drug
interventions is needed.15 16
Strengths and limitations of study
The strengths of this study include the wide range of
non-pharmacological interventions, duplicate rating, and the
verification of missing details and materials with authors.
However, 28% of authors did not respond, limiting the
completeness of this verification. A further limitation is that we
selected reports only from leading general medical journals,
and findings may not be generalisable. If the quality of reporting
of interventions is similar to the quality of reporting of
methodological features in randomised trials, which is better in
journals with a higher impact factor,17 then our study may have
underestimated the size of the problem. Our study may have
also found an even larger problem of poor reporting if we had
assessed whether the reports had evaluated or described the
fidelity of the intervention, which has been identified as an
additional element that should be included in descriptions of
interventions.5
Further work needed
Further work is needed in several areas. Firstly, we need to
better understand why authors do not provide more complete
descriptions of interventions. Secondly, we need to develop the
guidelines and tools to assist authors and editors in providing
complete descriptions of interventions. Several of the extensions
to the CONSORT statement have been motivated by a need to
obtain better details of interventions, but these differing
extensions need harmonisation to clarify what is generic and
what is specific to different types of interventions. As many
trials now publish a protocol, providing additional intervention
detail in the published protocol may be one way of overcoming
word limit restrictions in the trial’s primary paper. The recently
published reporting guideline for trial protocols, the SPIRIT
2013 Statement,18 contains four items (11a-d) about the reporting
of the intervention. Further work is needed to ensure that the
primary paper makes explicit mention of all related documents
(such as protocols, online supplementary material, and websites)
so that readers can easily obtain a complete description of the
intervention.
Although reporting standards are necessary, they are unlikely
to be sufficient. Development and enhancement of tools to assist
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with describing interventions would be useful. One such tool
is PatPlot,19 which provides a graphic depiction of the elements
and sequencing of complex interventions. However, given the
documented substantial deficiencies in reporting of interventions
and the demonstration that it is partly remediable, authors and
editors should take action now to reduce this waste in research.
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What is already known on this topic
Incomplete descriptions of interventions render the intervention uninterpretable and unusable by clinicians, patients, and researchers
The completeness of descriptions of interventions may be worse for non-pharmacological interventions than for pharmacological
interventions
What this study adds
Missing information is a common problem (occurring in more than 50%) in reports of non-pharmacological interventions
Details of intervention materials and procedures were the most commonly missing elements
The problem can be partially remediated by contacting authors of trial reports for missing details
Tables
Table 1| Items in checklist used to assess reports of randomised trials of non-pharmacological interventions
Elaboration of itemChecklist item
Is it clear where the intervention was delivered?Setting
Is it clear who received the intervention, and do you know all that you need to know about the participants?Recipient
Is it clear who delivered the intervention?Provider
Is the procedure (including the sequencing of the technique) of the intervention sufficiently clear to allow replication?Procedure
Are the physical or informational materials used adequately described (and available)?Materials
Is the dose/length of individual sessions of the intervention clear?Intensity
Is the schedule (interval, frequency, duration, or timing) of the intervention clear?Schedule
Is the description of the intervention complete?Missing (overall)
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Table 2| Publication source of trials (n=133) and categories of interventions (n=137) evaluated
No (%)Source/category
Journal
39 (29)BMJ
29 (22)JAMA
23 (17)New England Journal of Medicine
22 (17)Lancet
15 (11)Annals of Internal Medicine
5 (4)PLOS Medicine
Categories of interventions evaluated
23 (17)Education and training
23 (17)Device
19 (14)Surgery or perioperative intervention
17 (12)Complex intervention
16 (12)Diet
15 (11)Exercise or physical therapy
9 (7)Service delivery
8 (6)Other (such as sand as playground surface)
6 (4)Psychosocial intervention
1 (0.7)Complementary and alternative therapy
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Table 3| Examples of poor reporting of intervention elements in primary reports (key phrases underlined)
Reason for initial rating as “Not reported or not clearly
described”Verbatim examples of poor reporting*
Checklist
item
No details given about setting of intervention—for example,
outpatient setting, community setting, or in participants’ homes
(author clarified in an email)
“We conducted a randomised, sham-controlled study involving 24 patients with stroke
(11 men and 13 women). The median age was 62 years (range, 53 to 71), and the
median time since stroke was 14 months (range, 7 to 21).”
Setting
No details provided about who supervised training and their
role in supervising training
“The exercise training consisted of 36 sessions of supervised aerobic exercise training
(ie, walking, treadmill, or stationary cycling) at 60% to 70% of heart rate reserve 3
times per week followed by prescribed home-based training at the same intensity 5
times per week.”
Provider
Details of the procedure, including “standardised exercise
protocol” are not clear (author provided further details in an
email)
“Patients in the intervention group followed a standardised exercise protocol tailored
to individual achievement and were supervised by a physical therapist. The
programme consisted of a general warm up on a bicycle ergometer followed by static
and dynamic muscular exercises for the quadriceps, adductor, and gluteal muscles.
The programme also included balance exercises and flexibility exercises for major
thigh muscles.”
Procedure
Details of the behavioural counselling not clear (author
provided further details in an email)
“Behavioral counseling was integrated into the group and individual sessions to
promote adherence to the assigned diets.”
Procedure of intervention not clear“Based on previous research related to maternal dissatisfaction with peer support,
the peer volunteers were requested to make a minimum of four contacts and then
to interact as deemed necessary.”
Procedure of intervention not clear, and details about
accessing manual not provided in report (author provided
manual and details of procedure in an email)
“Patients randomised to the intervention joined amanual based, self directed, physical
rehabilitation programme developed by physiotherapists and introduced by a study
nurse.”
Materials
Neither script nor details about how to access it was provided
in report
“A 90-minute, semiscripted group session that was led by the genetic counsellor. .
.”
No details about accessing training materials were provided
in paper (authors provided materials after request via email)
“We offered two half day training seminars for 20 health professionals in each locality:
one on group facilitation skills led by an external consultant and one on trial conduct,
protocol, and data collection. We provided a written training pack and a password
protected website with access to all training materials.”
Duration of telephone calls (planned or actual) not reported
(author clarified in an email)
“The intervention was delivered by 1 nurse during bimonthly telephone calls.”Intensity
Length of counselling session not knownWe offered participants assigned to moderate-intensity disease management up to
2 telephone-based counselling sessions every 6 months (Ellerbeck)
“Specific intervals” are not provided (author clarified details
in an email)
“Each encounter included a core group of modules . . . plus additional modules
activated at specific intervals.”
Schedule
Not clear how long bimonthly sessions continued for (follow-up
in trial was 4 years)
“Nutritionists and dietitians gave dietary advice to participants in both groups in
monthly sessions in the first year and bimonthly sessions thereafter.”
*Details of sources of examples available on request.
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Figures
Fig 1 Percentage of interventions rated as adequately described, in primary report and after author reply, for each checklist
item
Fig 2 Illustration of process of obtaining complete description of an intervention (from: Effect of unsupervised home based
proprioceptive training on recurrences of ankle sprain: randomised controlled trial8)
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Fig 3 Access to and source of websites that contained additional intervention information
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